and Laboratory Standards Institute (CLSI) guidelines (M07-A10) [5] and interpreted as per CLSI guidelines (M100-S26). All the isolates were screened for polymyxin resistance using the rapid polymyxin NP test as previously described. [4] This test reagent contains cation-adjusted Mueller-Hinton broth, phenol red (pH indicator) and 10% anhydrous D(+)-glucose and colistin or polymyxin B at a final concentration of 5 µg/ml. This test involved incubation under aerobic conditions to improve glucose metabolism and accuracy of the results.
and Laboratory Standards Institute (CLSI) guidelines (M07-A10) [5] and interpreted as per CLSI guidelines (M100-S26). All the isolates were screened for polymyxin resistance using the rapid polymyxin NP test as previously described. [4] This test reagent contains cation-adjusted Mueller-Hinton broth, phenol red (pH indicator) and 10% anhydrous D(+)-glucose and colistin or polymyxin B at a final concentration of 5 µg/ml. This test involved incubation under aerobic conditions to improve glucose metabolism and accuracy of the results.
All the pathogens intrinsically resistant to polymyxin were found to be resistant to polymyxin B and colistin with the rapid polymyxin NP test (100%). Among the tested isolates, 30% (n = 37) of Klebsiella sp. and 18% (n = 9) of Enterobacter sp. were found to be resistant to both colistin and polymyxin B using both BMD and polymyxin NP Dear Editor, Increasing multi-drug resistance (MDR) in Gram-negative pathogens has caused considerable therapeutic challenges in clinical practice. This has resulted in an increase in the use of polymyxins in treating MDR infections. However, chromosomal or plasmid-mediated (mcr-1 and mcr-2) polymyxin resistance are being increasingly reported worldwide. [1] [2] [3] Molecular methods are not always effective in detecting chromosomally-encoded polymyxin resistance. For polymyxin susceptibility testing, conventional methods such as disc diffusion and E-test are not reliable, while the standard reference technique of broth microdilution (BMD) is time-consuming (24 h). [4] Moreover, rapid and reliable methods for testing colistin or polymyxin B in the clinical settings are essential for timely and effective patient management. Recently, a rapid polymyxin Nordmann/Poirel (NP) test was developed for detection of polymyxin resistance in Enterobacteriaceae. [4] We sought to evaluate the performance of the rapid polymyxin NP test in detecting polymyxin resistance.
A total of 232 non-duplicate Enterobacteriaceae isolates recovered from bloodstream infection during 2014-2015 were randomly selected and included in this study. This collection included carbapenem-resistant Klebsiella sp., (n = 122) and Enterobacter sp., (n = 50) and intrinsically polymyxin-resistant Proteus mirabilis (n = 30), Morganella morganii (n = 15) and Serratia marcescens (n = 15) as an internal control. Minimum inhibitory concentration (MIC) of colistin and polymyxin B against Enterobacteriaceae isolates (Klebsiella sp., and Enterobacter sp.,) was determined using the BMD method according to the Clinical Interestingly, heteroresistance to colistin and polymyxin B was observed in Klebsiella pneumonaie isolate (n = 1) and this was found to be positive in the rapid polymyxin NP test [ Figure 1] . A majority of the tested isolates showed positivity in the rapid polymyxin NP test in <3 h.
The rapid polymyxin NP test is based on the metabolism of glucose by bacterial growth in the presence of defined concentration of colistin or polymyxin B. The acid metabolites produced are detected by a colour change (orange to yellow) of the phenol red pH indicator. This test was reported to have a sensitivity and specificity of 99.3% and 95.4%, respectively. [4] However, false positive results (30%) were reported while using bacterial colonies recovered from acidifying media. [4] In comparison, this study has shown the sensitivity and specificity of the rapid polymyxin NP test to be 100%; moreover, none of the tested isolates showed false-positive or false-negative results. Similarly, the performance of the rapid polymyxin NP test was reported to be excellent in early identification of polymyxin-resistant Enterobacteriaceae directly from the supernatant of the positive blood cultures (monomicrobial). [6] It is well known that polymyxin susceptibility testing with Enterobacter sp., may results in multiple skip wells and this may lead to uninterpretable results, and therefore, the results should be performed with extreme caution. [7] However, in the present study, the tested Enterobacter sp. showed multiple skip wells at higher dilutions (MIC >8 µg/ml) rather than at the lower dilutions.
Susceptibility testing of polymyxin is challenging due to the (i) poorly defined relative proportion of polymyxin components, (ii) cationic property of polymyxin and (iii) heteroresistance to colistin/polymyxin B in MDR pathogens. In comparison with BMD (reference method), rapid polymyxin NP showed excellent discrimination between polymyxin susceptible and polymyxin-resistant enterobacterial isolates. It is easy to perform, rapid, reliable and cost-effective. Rapid polymyxin NP is a potential screening method for detecting polymyxin resistance in Enterobacteriaceae.
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